Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.070
+0.480 (13.37%)
Aug 7, 2026, 3:41 PM EDT - Market open
Evolent Health Revenue
Evolent Health had revenue of $652.52M in the quarter ending June 30, 2026, with 46.86% growth. This brings the company's revenue in the last twelve months to $2.10B, down -4.50% year-over-year. In the year 2025, Evolent Health had annual revenue of $1.88B, down -26.56%.
Revenue (ttm)
$2.10B
Revenue Growth
-4.50%
P/S Ratio
0.21
Revenue / Employee
$499,290
Employees
4,200
Market Cap
458.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.88B | -678.51M | -26.56% |
| Dec 31, 2024 | 2.55B | 590.85M | 30.09% |
| Dec 31, 2023 | 1.96B | 611.88M | 45.26% |
| Dec 31, 2022 | 1.35B | 444.06M | 48.91% |
| Dec 31, 2021 | 907.96M | -16.68M | -1.80% |
| Dec 31, 2020 | 924.64M | 237.52M | 34.57% |
| Dec 31, 2019 | 687.12M | 60.06M | 9.58% |
| Dec 31, 2018 | 627.06M | 192.11M | 44.17% |
| Dec 31, 2017 | 434.95M | 180.76M | 71.11% |
| Dec 31, 2016 | 254.19M | 157.31M | 162.38% |
| Dec 31, 2015 | 96.88M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 25.67M | 17.33M | 207.58% |
| Dec 31, 2012 | 8.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Claritev | 978.76M |
| Health Catalyst | 302.48M |
| Weave Communications | 248.72M |
| So-Young International | 240.51M |
| American Well | 218.53M |
| LifeMD | 191.59M |
| NRC Health | 140.00M |
| Spok Holdings | 135.97M |
EVH News
- 1 day ago - Evolent Health Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Evolent Health Earnings release: Q2 2026 - Filings
- 1 day ago - Evolent Health Slides: Q2 2026 - Filings
- 1 day ago - Evolent Health Quarterly report: Q2 2026 - Filings
- 1 day ago - Evolent Health reports Q2 adjusted EPS 2c, consensus (2c) - TheFly
- 1 day ago - Evolent Health raises 2026 revenue view to $2.6B-$2.7B from $2.4B-$2.6B - TheFly
- 1 day ago - Evolent Announces Second Quarter 2026 Results - PRNewsWire
- 10 days ago - Evolent Health price target lowered to $5 from $8 at TD Cowen - TheFly